All News Top News Aug 20, 2019 Teva Announces Availability of a Generic Equivalent of EpiPen Jr® (epinephrine injection, USP) Auto-Injector, 0.15 mg in the United States Learn More Share Top News Aug 7, 2019 Teva Announces CFO Leadership Transition Learn More Share Top News Aug 7, 2019 Teva Reports Second Quarter 2019 Financial Results Learn More Share Top News Jul 15, 2019 Teva Announces FDA Approval of AirDuo® Digihaler™ (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder Learn More Share Top News Jul 11, 2019 Teva Drives Progress to Address Pressing Global Health Challenges While Maintaining Focus on Compliance Learn More Share
Top News Aug 20, 2019 Teva Announces Availability of a Generic Equivalent of EpiPen Jr® (epinephrine injection, USP) Auto-Injector, 0.15 mg in the United States Learn More
Top News Jul 15, 2019 Teva Announces FDA Approval of AirDuo® Digihaler™ (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder Learn More
Top News Jul 11, 2019 Teva Drives Progress to Address Pressing Global Health Challenges While Maintaining Focus on Compliance Learn More